Loading...

No Effect of Levothyroxine and Levothyroxine-Induced Subclinical Thyrotoxicosis on the Pharmacokinetics of Sorafenib in Healthy Male Subjects

Background: Patients receiving the multikinase inhibitor sorafenib for locally recurrent or metastatic, progressive, differentiated thyroid carcinoma (DTC) refractory to radioactive iodine often receive concomitant levothyroxine for thyrotropin (TSH) suppression. In the Phase 3 DTC trial (DECISION),...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Thyroid
Main Authors: Huang, Funan, Ajavon, Antoinette, Huang, Erya, Lettieri, John, Liu, Rong, Peña, Carol, Berse, Matthias
Format: Artigo
Sprog:Inglês
Udgivet: Mary Ann Liebert, Inc. 2017
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5646750/
https://ncbi.nlm.nih.gov/pubmed/28741453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/thy.2017.0085
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!